Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.

Citalopram is a potent and selective inhibitor of neuronal serotonin uptake. In rat brain membranes [3H]citalopram demonstrates saturable and reversible binding with a KD of 0.8 nM and a maximal number of binding sites (Bmax) of 570 fmol/mg of protein. The drug specificity for [3H]citalopram binding and synaptosomal serotonin uptake are closely correlated. Inhibition of [3H]citalopram binding by both serotonin and imipramine is consistent with a competitive interaction in both equilibrium and kinetic analyses. The autoradiographic pattern of [3H]citalopram binding sites closely resembles the distribution of serotonin. By contrast, detailed equilibrium-saturation analysis of [3H]imipramine binding reveals two binding components, i.e., high affinity (KD = 9 nM, Bmax = 420 fmol/mg of protein) and low affinity (KD = 553 nM, Bmax = 8560 fmol/mg of protein) sites. Specific [3H]imipramine binding, defined as the binding inhibited by 100 microM desipramine, is displaced only partially by serotonin. Various studies reveal that the serotonin-sensitive portion of binding corresponds to the high affinity sites of [3H]imipramine binding whereas the serotonin-insensitive binding corresponds to the low affinity sites. Lesioning of serotonin neurons with p-chloroamphetamine causes a large decrease in [3H]citalopram and serotonin-sensitive [3H]imipramine binding with only a small effect on serotonin-insensitive [3H]imipramine binding. The dissociation rate of [3H]imipramine or [3H]citalopram is not altered by citalopram, imipramine or serotonin up to concentrations of 10 microM. The regional distribution of serotonin sensitive [3H]imipramine high affinity binding sites closely resembles that of [3H]citalopram binding.(ABSTRACT TRUNCATED AT 250 WORDS)

• Publication year

  1987

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  1987-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/s0022-3565(25)39080-4PMID 3475452
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rapid and simple method for measuring biogenic amines and metabolites in brain homogenates by HPLC-electrochemical detection

  2005cited by this paper
• Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.

  1986cited by this paper
• Examination of the relationship between the uptake system for 5-hydroxytryptamine and the high-affinity [3H]imipramine binding site—I Inhibition by drugs

  1986cited by this paper
• Subdivision of Mouse Brain [3H]Imipramine Binding Based on Ion Dependence and Serotonin Sensitivity

  1986cited by this paper
• Effect of serotonin on the dissociation of high-affinity binding of [3H]imipramine in mouse cerebral cortex.

  1986cited by this paper
• High‐ and Low‐Affinity Binding Components for [3H]Imipramine in Rat Cerebral Cortex

  1985cited by this paper
• Characterization of [3H]paroxetine binding to rat cortical membranes.

  1985cited by this paper
• Serotonin uptake inhibitors differentially modulate high affinity imipramine dissociation in human platelet membranes.

  1985cited by this paper
• Quantitative Autoradiography of [3H]Indalpine Binding Sites in the Rat Brain: II. Regional Distribution

  1985cited by this paper
• “Specific” Binding of [3H]Imipramine to Protease‐Sensitive and Protease‐Resistant Sites

  1985cited by this paper
• Quantitative receptor autoradiography with tritium-labeled ligands: comparison of biochemical and densitometric measurements.

  1984cited by this paper
• Differentiation of two components of specific [3H]imipramine binding in rat brain.

  1984cited by this paper
• [3H]Imipramine Labels Sites on Brain Astroglial Cells Not Related to Serotonin Uptake

  1983cited by this paper
• Lack of association between [3H]imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients.

  1983cited by this paper
• A practical computer-based approach to the analysis of radioligand binding experiments.

  1983cited by this paper
• Complex Inhibition of [3H]Imipramine Binding by Serotonin and Nontricyclic Serotonin Uptake Blockers

  1983cited by this paper
• Autoradiographic localization of [3H]-imipramine binding sites: association with serotonergic neurons.

  1983cited by this paper
• High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes.

  1983cited by this paper
• Ontogenetic study of [3H]imipramine binding sites and serotonin uptake system: indication of possible interdependence.

  1982cited by this paper
• Distribution of Specific High‐Affinity Binding Sites for [3H]Imipramine in Human Brain

  1981cited by this paper
• Demonstration of specific high affinity binding sites for [3H] imipramine in human brain.

  1980cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• High-affinity 3H-imipramine binding in rat cerebral cortex.

  1979cited by this paper

• Preliminary Screening of South African Plants for Binding Affinity to the Serotonin Reuptake Transporter and Adenosine A1/A2A Receptors

  2023cites this paper
• Pharmacological characterization of 3,4-methylenedioxamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA.

  2022cites this paper
• Comparative analysis of novel decynium‐22 analogs to inhibit transport by the low‐affinity, high‐capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter

  2019cites this paper
• Conformational dynamics of the human serotonin transporter during substrate and drug binding

  2019cites this paper
• Enteric nervous system development: what could possibly go wrong?

  2018cites this paper
• Pharmacological profile of methylphenidate-based designer drugs.

  2017cites this paper
• Targeting the Serotonin (5-HT) system to control seizures

  2017cites this paper
• Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications

  2017cites this paper
• Differential effects of perinatal exposure to antidepressants on learning and memory, acoustic startle, anxiety, and open‐field activity in Sprague‐Dawley rats

  2017cites this paper
• Azidobupramine, an Antidepressant-Derived Bifunctional Neurotransmitter Transporter Ligand Allowing Covalent Labeling and Attachment of Fluorophores

  2016cites this paper
• Ontogeny of SERT Expression and Antidepressant-like Response to Escitalopram in Wild-Type and SERT Mutant Mice

  2016cites this paper
• Nuclear medicine for the investigation of canine behavioral disorders

  2016cites this paper
• Antidepressant Effects in Hybrid Striped Bass: Moving from External Exposures to Internal Doses

  2015influential citation
• Tph2 gene deletion enhances amphetamine‐induced hypermotility: effect of 5‐HT restoration and role of striatal noradrenaline release

  2015cites this paper
• Changes in dopamine transporter binding in nucleus accumbens following chronic self‐administration cocaine: Heroin combinations

  2014cites this paper
• An altered spinal serotonergic system contributes to increased thermal nociception in an animal model of depression

  2014cites this paper
• Design of novel multiple-acting ligands towards SERT and 5-HT2C receptors.

  2014cites this paper
• Characterization of FlipIDAM as a SERT-selective SPECT imaging agent.

  2013cites this paper
• Iodoreboxetine : the development of a novel SPECT brain imaging tracer for the noradrenaline transporter

  2013cites this paper
• Antidepressant-like drug effects in juvenile and adolescent mice in the tail suspension test: Relationship with hippocampal serotonin and norepinephrine transporter expression and function

  2013cites this paper
• RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis

  2013cites this paper
• Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects

  2012cites this paper
• The Mechanistic Basis for Noncompetitive Ibogaine Inhibition of Serotonin and Dopamine Transporters*

  2012cites this paper
• Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humans

  2012cites this paper
• The Effects of Chronic Ethanol Self-Administration on Hippocampal Serotonin Transporter Density in Monkeys

  2012cites this paper
• Differential regulation of serotonin transporter cell surface expression

  2012cites this paper
• Discovery of Novel Histamine H4 and Serotonin Transporter Ligands Using the Topological Feature Tree Descriptor

  2012cites this paper
• Acute 5-HT1A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions

  2012cites this paper
• Development of radiosynthesis methods for 18F-labelled radiopharmaceuticals : General considerations and production of a dopamine transporter radioligand

  2011cites this paper
• Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.

  2011cites this paper
• Characterization of 5-HT transporter and receptor system in HeLaS3 cells by [(3)H]8-OH-DPAT and other serotonergic ligands.

  2011cites this paper
• Presynaptic control of serotonin on striatal dopamine function

  2011cites this paper
• Dystrophic Serotonin Axons in Postmortem Brains from Young Autism Patients

  2011cites this paper
• Cibles sérotoninergiques et non sérotoninergiques des ISRS : approches pharmacologique et génétique in vivo chez la souris

  2011cites this paper
• Density and function of central serotonin (5‐HT) transporters, 5‐HT1A and 5‐HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior

  2011cites this paper
• Comparison of 2β-Carbomethoxy-3β-(4-[18F]Fluorophenyl)Tropane and N-(3-[18F]Fluoropropyl)-2β-Carbomethoxy-3β-(4-Fluorophenyl)Nortropane, Tracers for Imaging Dopamine Transporter in Rat

  2010cites this paper
• Stress-Induced Hyperthermia, the Serotonin System and Anxiety

  2010cites this paper
• Serotonin modulates glutamatergic transmission in the rat olfactory tubercle

  2010cites this paper
• Impact of Ovarian Hormones on the Modulation of the Serotonin Transporter by Fluvoxamine

  2009cites this paper
• 1-Naphthyl and 4-indolyl arylalkylamines as selective monoamine reuptake inhibitors.

  2009cites this paper
• Association of Changes in Norepinephrine and Serotonin Transporter Expression with the Long-Term Behavioral Effects of Antidepressant Drugs

  2009cites this paper
• Ex vivo evaluation of N-(3-[18F]fluoropropyl)-2 beta-carbomethoxy-3 beta-(4-fluorophenyl)nortropane in rats.

  2008cites this paper
• Ex vivo assessment of binding site occupancy of monoamine reuptake inhibitors: methodology and biological significance.

  2008cites this paper
• Functional Anatomy of the Enteric Nervous System

  2008cites this paper
• In Vivo Characterization of a Novel Phenylisothiocyanate Tropane Analog at Monoamine Transporters in Rat Brain

  2008cites this paper
• Antidepressants Targeting the Serotonin Reuptake Transporter Act via a Competitive Mechanism

  2008cites this paper
• Phenotyping the serotonin transporter knockout rat: a behavioural, pharmacological and physiological approach. A new animal model of human serotonergic disorders.

  2008cites this paper
• The comparative distributions of the monoamine transporters in the rodent, monkey, and human amygdala

  2008cites this paper
• Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system.

  2008cites this paper
• Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.

  2008cites this paper
• Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders

  2008cites this paper
• Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype.

  2008cites this paper
• [(3)H] citalopram binding to serotonin transporter sites in minnow brains.

  2007cites this paper
• Irreversible binding of a novel phenylisothiocyanate tropane analog to monoamine transporters in rat brain.

  2007cites this paper
• Pharmacological properties of the active metabolites of the antidepressants desipramine and citalopram.

  2007influential citation
• Imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel SPECT ligand [123I]-ADAM

  2006cites this paper
• Serotonin transporter and dopamine transporter imaging in the canine brain.

  2006cites this paper
• The serotonin transporter in rhesus monkey brain: comparison of DASB and citalopram binding sites.

  2006cites this paper
• A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters.

  2006cites this paper
• Lower3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high affinity, non-transporter sites

  2005cites this paper
• Regional studies of serotonin and dopamine metabolism and quantification of serotonin uptake sites in human cerebral cortex

  2005cites this paper
• 5-HT1B receptors and aggression: a review.

  2005cites this paper
• [3H]Paroxetine and [3H]citalopram as markers of the human brain 5-HT uptake site: a comparison study

  2005cites this paper
• n Vivo Neuroreceptor Imaging in Attention-Deficit / yperactivity Disorder : A Focus on The Dopamine ransporter

  2005cites this paper
• Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei.

  2005cites this paper
• Opioid receptor‐like 1 (NOP) receptors in the rat dorsal raphe nucleus: Evidence for localization on serotoninergic neurons and functional adaptation after 5,7‐dihydroxytryptamine lesion

  2005cites this paper
• [3H] sertraline binding to rat brain membranes

  2005cites this paper
• The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system

  2005cites this paper
• Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity.

  2005cites this paper
• Comparison of the subregional distributions of the monoamine vesicular transporter and dopamine uptake complex in the rat striatum and changes during aging

  2005cites this paper
• Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets

  2005cites this paper
• The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine

  2005cites this paper
• In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter.

  2005cites this paper
• Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats.

  2004cites this paper
• Drug inhibition indicates a single-site model of the 5-HT uptake site/antidepressant binding site in rat and human brain

  2004cites this paper
• Serotonin and Aggression

  2004cites this paper
• Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats.

  2004cites this paper
• Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression.

  2004cites this paper
• A 5-HT(2C) receptor-mediated interaction between 2,5-dimethoxy-4-methylamphetamine and citalopram in the rat.

  2004cites this paper
• DASB –in vitro binding characteristics on human recombinant monoamine transporters with regard to its potential as positron emission tomography (PET) tracer

  2004cites this paper
• Serotonergic platelet markers of suicidal behavior--do they really exist?

  2004cites this paper
• S‐[18F]fluoromethyl‐(+)‐McN5652, a PET tracer for the serotonin transporter: Evaluation in rats

  2003influential citation
• Antidepressant-Induced Increase in High-Affinity Rolipram Binding Sites in Rat Brain: Dependence on Noradrenergic and Serotonergic Function

  2003cites this paper
• Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression

  2003cites this paper
• Modulation of serotonin transporter function and pharmacology by subunit interactions and an endogenous regulatory factor.

  2003cites this paper
• Pharmacological Characterization ofN,N-Dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a Ligand of the Serotonin Transporter with High Affinity and Selectivity

  2003cites this paper
• Citalopram

  2003influential citation
• Serotonin Transporter: A Potential Substrate in the Biology of Suicide

  2003cites this paper
• GABAB receptor mRNA in the raphe nuclei: co‐expression with serotonin transporter and glutamic acid decarboxylase

  2003cites this paper
• Changes in Human In vivo Serotonin and Dopamine Transporter Availabilities during Chronic Antidepressant Administration

  2003cites this paper
• Autoradiographic imaging of the serotonin transporter in the brain of rats and pigs using S-([18F]fluoromethyl)-(+)-McN5652.

  2003cites this paper
• Regional pattern of binding and c-Fos induction by (R)- and (S)-citalopram in rat brain

  2003cites this paper
• Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4'-fluorophenyl)-3-(4'phenylphenoxy)propyl])sarcosine.

  2003cites this paper
• Biochemical and behavioral characterization of novel methylphenidate analogs.

  2002cites this paper
• Comparative evaluation of two serotonin transporter ligands in the human brain: [11C](+)McN5652 and [11C]cyanoimipramine

  2002cites this paper
• Comparative evaluation of two serotonin transporter ligands in the human brain: [(11)C](+)McN5652 and [(11)C]cyanoimipramine.

  2002cites this paper
• Changes in serotonin, serotonin transporter expression and serotonin denervation supersensitivity: involvement in chronic central pain after spinal hemisection in the rat.

  2002cites this paper
• Trishomocubanes: novel σ-receptor ligands modulate amphetamine-stimulated [3H]dopamine release

  2001cites this paper
• The Effects of Hypothyroidism on 5-HT1A and 5-HT2A Receptors and the Serotonin Transporter Protein in the Rat Brain

  2001cites this paper
• [11C,127I] Altropane: A highly selective ligand for PET imaging of dopamine transporter sites

  2001influential citation